本页面由Tiger Trade Technology Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

24.20
-0.1900-0.78%
盘后24.200.00000.00%17:21 EST
成交量:149.12万
成交额:3,632.40万
市值:19.04亿
市盈率:-13.40
高:25.17
开:24.19
低:24.00
收:24.39
52周最高:36.26
52周最低:2.86
股本:7,865.99万
流通股本:5,314.44万
量比:1.29
换手率:2.81%
股息:- -
股息率:- -
每股收益(TTM):-1.8064
每股收益(LYR):-2.2041
净资产收益率:-59.22%
总资产收益率:-34.41%
市净率:6.19
市盈率(LYR):-10.98

数据加载中...

2026/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

重要事件披露

Form 8-K - Current report
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

重要事件披露

Form 8-K - Current report